Inflammatory Bowel Disease (IBD) Therapeutics Market Share

Statistics for the 2023 & 2024 Inflammatory Bowel Disease (IBD) Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Inflammatory Bowel Disease (IBD) Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Inflammatory Bowel Disease (IBD) Therapeutics Industry

The inflammatory bowel disease (IBD) therapeutics market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies that are currently dominating the market are Bristol-Myers Squibb Company, AbbVie Inc., Allergan Therapeutics LLC, Bausch Health Companies Inc. (Salix Pharmaceuticals), Rare Disease Therapeutics Inc., Johnson & Johnson Services Inc., Janssen Biotech, Inc., UCB Inc., and others.

Inflammatory Bowel Disease (IBD) Therapeutics Market Leaders

  1. Bristol-Myers Squibb Company

  2. AbbVie Inc.

  3. Takeda Pharmaceutical Company Limited

  4. Johnson & Johnson Services Inc. (Janssen Biotech, Inc.)

  5. Bausch Health Companies Inc. (Salix Pharmaceuticals)

*Disclaimer: Major Players sorted in no particular order

Inflammatory Bowel Disease (IBD) Therapeutics Market Concentration

Inflammatory bowel disease (IBD) Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)